Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.

This study compares the clinical effectiveness of Intravenous Immunoglobulin (IVIG) versus Plasma Exchange (PLEX) in patients experiencing a myasthenic crisis. Clinical response is evaluated 14 days post-treatment using the Quantitative Myasthenia Gravis Score (QMG). Additionally, the study aims to identify and report common precipitating factors for myasthenic attacks, such as respiratory infections or surgical stress.

NCT Number	NCT07532707
Lead Sponsor	Damascus University Collaborators: Al Mouwasat Hospital, Al-Assad University Hospital
Conditions	Myasthenic Crisis, Myasthenia Gravis (MG)
Enrollment	50 participants
Start Date	2022-09-01
Primary Completion	2023-10-15 (estimated)
Study Completion	2023-10-30 (estimated)
Updated on ClinicalTrials.gov	2026-04-16